Injective INJ
Current Price
$3.01 +3.73%
$0.1700 Daily Range (5.65%)
$2.89$3.06
$46.51M Daily Volume
626 BTC
Vol/MktCap: 15.42%
Market Performance
0.08% Relative BTC Volume
The total volume of Injective is $46.51M over the past 24 hours, compared to $55.09B total Bitcoin volume.
Hourly Moving Average
8 SMA $2.98 +0.93%
13 SMA $2.96 +1.54%
21 SMA $2.94 +2.29%
55 SMA $2.94 +2.55%
144 SMA $2.97 +1.49%
Price Performance
-1.27% 1 Hour Change
$3.01 from $3.05
+6.05% 7 Day Change
$0.1822 from $2.83
+4.36% 14 Day Change
$0.1313 from $2.88
-1.57% 30 Day Change
-$0.0473 from $3.06
All Time High
March 14, 2024
$52.62 -94.25%
-$49.59 vs. now
24H Change
11.41M USD +3.93%
154 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
5.00 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
15.63M INJ
traded over past 24 hours
15.63% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently priced at $3.03, reflecting a 4.60% increase over the past 24 hours. The price has fluctuated between a low of $2.89 and a high of $3.06 during this period, indicating a stable daily range of 0.17%.
Trading volume over the last 24 hours stands at approximately $46.5 million, which corresponds to a volume-to-market cap ratio of 15.33%. This suggests a healthy trading activity relative to its market capitalization, supporting a bullish sentiment.
Analyzing the hourly moving averages, the 8 SMA is at $2.98 (+1.60%), while the 13 SMA is at $2.96 (+2.22%). These upward trends in short-term moving averages indicate a positive momentum in the market.
The 1-hour RSI is currently at 74, suggesting that INJ is in overbought territory, which could signal a potential short-term pullback. Conversely, the 7-day RSI at 50 indicates neutral momentum, reflecting a balance between buyers and sellers over a longer timeframe.
From a price change perspective, INJ has seen a 6.75% increase over the past week, supported by a 5.05% rise over the last 14 days. However, the 30-day change shows a slight decline of -0.93%, indicating some recent bearish pressure that could affect longer-term sentiment.
Given the all-time high of $52.62 reached in March 2024, current prices are significantly lower, suggesting potential upside for long-term investors. However, the overbought conditions indicated by the 1-hour RSI may pose risks for short-term traders.
Considering the overall analysis, the recommendation for Injective (INJ) is to Hold. The combination of strong short-term price action and potential overbought conditions warrants caution, while longer-term prospects remain positive.
Trading volume over the last 24 hours stands at approximately $46.5 million, which corresponds to a volume-to-market cap ratio of 15.33%. This suggests a healthy trading activity relative to its market capitalization, supporting a bullish sentiment.
Analyzing the hourly moving averages, the 8 SMA is at $2.98 (+1.60%), while the 13 SMA is at $2.96 (+2.22%). These upward trends in short-term moving averages indicate a positive momentum in the market.
The 1-hour RSI is currently at 74, suggesting that INJ is in overbought territory, which could signal a potential short-term pullback. Conversely, the 7-day RSI at 50 indicates neutral momentum, reflecting a balance between buyers and sellers over a longer timeframe.
From a price change perspective, INJ has seen a 6.75% increase over the past week, supported by a 5.05% rise over the last 14 days. However, the 30-day change shows a slight decline of -0.93%, indicating some recent bearish pressure that could affect longer-term sentiment.
Given the all-time high of $52.62 reached in March 2024, current prices are significantly lower, suggesting potential upside for long-term investors. However, the overbought conditions indicated by the 1-hour RSI may pose risks for short-term traders.
Considering the overall analysis, the recommendation for Injective (INJ) is to Hold. The combination of strong short-term price action and potential overbought conditions warrants caution, while longer-term prospects remain positive.
Updated 36 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

Bitcoin erases weekend decline, returns to $73,400 as oil retreats back under $100
Risk assets shrugged off the failed weekend negotiations between the U.S. and Iran, and the U.S.

2028 Election Prediction Markets: JD Vance Leads Despite VP’s Historic Approval Low
JD Vance entered the vice presidency with a modest net positive approval rating and has since watched it fall 21 points in roughly 15 months.

Bitcoin Shrugs off Strait of Hormuz Blockade to Hit $72,629 Intraday High
Bitcoin staged a market-defying recovery on Monday, April 13, rising to an intraday high of $72,629 shortly after reclaiming the $72,000 level.

Dollar’s Shrinking Value Adds Fuel To XRP Bull Case: Finance Expert
XRP has lost 38% of its value over the past year. Bitcoin hasn’t done much better, sliding more than 16%.